{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:33:16Z","timestamp":1768451596925,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.pathol.2021.01.010","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T11:39:48Z","timestamp":1620301188000},"page":"728-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-3923","authenticated-orcid":false,"given":"Fabien","family":"Forest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Habougit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Corbasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bayle-Bleuez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Fournel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Tiffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"P\u00e9oc'h","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.01.010_bib1","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.pathol.2021.01.010_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0000000000001416","article-title":"Utility of nuclear grading system in epithelioid malignant pleural mesothelioma in biopsy-heavy setting","volume":"44","author":"Zhang","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.01.010_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/modpathol.2017.170","article-title":"Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study","volume":"31","author":"Rosen","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.010_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A\u00a0nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.01.010_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00428-017-2109-z","article-title":"Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies","volume":"470","author":"Habougit","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.01.010_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/his.14127","article-title":"Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade","volume":"77","author":"Zhang","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2021.01.010_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","article-title":"EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach","volume":"15","author":"Nicholson","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2021.01.010_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-019-0583-3","article-title":"Deep learning-based classification of mesothelioma improves prediction of patient outcome","volume":"25","author":"Courtiol","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2021.01.010_bib9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jtho.2020.01.025","article-title":"Comprehensive molecular and pathologic evaluation of transitional mesothelioma assisted by deep learning approach: a multi-institutional study of the International Mesothelioma Panel from the MESOPATH Reference Center","volume":"15","author":"Galateau Salle","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2021.01.010_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jclinpath-2016-203993","article-title":"Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma","volume":"70","author":"Alchami","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2021.01.010_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00428-018-2408-z","article-title":"Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations","volume":"473","author":"van Pelt","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.01.010_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2021.01.010_bib13","series-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"key":"10.1016\/j.pathol.2021.01.010_bib14","series-title":"A\u00a0package for survival analysis in S","author":"Therneau","year":"2021"},{"key":"10.1016\/j.pathol.2021.01.010_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in The Cancer Genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2021.01.010_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2021.01.010_bib17","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.pathol.2021.01.010_bib18","first-page":"187","article-title":"Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model","volume":"11","author":"Galffy","year":"1999","journal-title":"Oncol Res"},{"key":"10.1016\/j.pathol.2021.01.010_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.32419","article-title":"Wnt\/IL-1\u03b2\/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5","volume":"146","author":"Milosevic","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2021.01.010_bib20","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.4049\/jimmunol.1000225","article-title":"Enrichment of Foxp3\u00a0+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6","volume":"185","author":"Eikawa","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2021.01.010_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.pathol.2018.05.002","article-title":"Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications","volume":"50","author":"Forest","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2021.01.010_bib22","article-title":"Multiple therapeutic pathways in malignant mesothelioma identified by genomic mapping","volume":"Mar 30","author":"Nastase","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.pathol.2021.01.010_bib23","first-page":"1","article-title":"Integrated genome-wide methylation and expression analyses reveal key regulators in osteosarcoma","volume":"13","author":"Wang","year":"2020","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.pathol.2021.01.010_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5136","article-title":"Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression","volume":"6","author":"Han","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.pathol.2021.01.010_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s43018-020-0085-8","article-title":"Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis","volume":"1","author":"Fu","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.pathol.2021.01.010_bib26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.molonc.2016.07.004","article-title":"LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome","volume":"10","author":"Ramirez-Ardila","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.pathol.2021.01.010_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2020.07.010","article-title":"Histopathological subtyping is a prognostic factor in stage IV lung adenocarcinoma","volume":"147","author":"Da Cruz","year":"2020","journal-title":"Lung Cancer"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T03:43:41Z","timestamp":1655091821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0031302521000933"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.01.010","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}